Arriello Announces Signing of First US Company to Use IntelliCASE for...

The innovative mobile app, which converts natural language into text, will allow clinical trial participants of any nationality to record any adverse effects directly into a PV database, while...(PRWeb January 26, 2021)Read the full story at https://www.prweb.com/releases/arriello_announces_signing_of_first_us_company_to_use_intellicase_for_clinical_pharmacovigilance_reporting/prweb17676102.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news